1 new0 added5 reduced29 sold outnet sold ≈ $11.2m (-481.8k shares)
* Summed across managers. Shares that two managers' reports both contain – a
subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are
counted once.
Holder counts are more reliable.
Implied quarter-end price ≈ $23.33.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
Quarter
Holders
Q3 2024
1
Q4 2024
46
Q1 2025
36
Q2 2025
7
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D
if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the
stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder
worked them out.
Holder
Stake
Change
Shares
Last filed
Sporos Bioventures LLC
13G · exempt (held before listing)new · filed 2025-08-08